Sympathetic nerve-enteroendocrine L cell communication modulates GLP-1 release, brain glucose utilization, and cognitive function

被引:10
|
作者
Ren, Wenran [1 ,2 ,3 ,7 ]
Chen, Jianhui [1 ,2 ,3 ,7 ]
Wang, Wenjing [6 ]
Li, Qingqing [1 ,2 ,3 ,7 ]
Yin, Xia [6 ]
Zhuang, Guanglei [6 ]
Zhou, Hong [5 ]
Zeng, Wenwen [1 ,2 ,3 ,4 ,7 ]
机构
[1] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China
[2] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China
[3] Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China
[4] Shanxi Med Univ, SXMU Tsinghua Collaborat Innovat Ctr Frontier Med, Taiyuan 030001, Shanxi, Peoples R China
[5] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Gastrointestinal Surg, Shanghai 200127, Peoples R China
[6] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Shanghai Key Lab Gynecol Oncol, Shanghai 200127, Peoples R China
[7] Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China
基金
中国国家自然科学基金; 北京市自然科学基金; 国家重点研发计划;
关键词
GLUCAGON-LIKE PEPTIDE-1; INSULIN-RESISTANCE; ENDOGENOUS GLP-1; PHOTOACOUSTIC TOMOGRAPHY; HIGH-RESOLUTION; RECEPTORS; SECRETION; MEDIATE; SYSTEM; ACTIVATION;
D O I
10.1016/j.neuron.2023.12.012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glucose homeostasis is controlled by brain-gut communications. Yet our understanding of the neuron-gut interface in the glucoregulatory system remains incomplete. Here, we find that sympathetic nerves elevate postprandial blood glucose but restrict brain glucose utilization by repressing the release of glucagon-like peptide-1 (GLP-1) from enteroendocrine L cells. Sympathetic nerves are in close apposition with the L cells. Importantly, sympathetic denervation or intestinal deletion of the adrenergic receptor a2 (Adra2a) augments postprandial GLP-1 secretion, leading to reduced blood glucose levels and increased brain glucose uptake. Conversely, sympathetic activation shows the opposite effects. At the cellular level, adrenergic signaling suppresses calcium flux to limit GLP-1 secretion upon sugar ingestion. Consequently, abrogation of adrenergic signal results in a significant improvement in learning and memory ability. Together, our results reveal a sympathetic nerve-enteroendocrine unit in constraining GLP-1 secretion, thus providing a therapeutic nexus of mobilizing endogenous GLP-1 for glucose management and cognitive improvement.
引用
收藏
页码:972 / 990.e8
页数:28
相关论文
共 42 条
  • [31] Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic β-cell function after 3-week daily administration in obese diabetic (ob/ob) mice
    Green, Brian D.
    Lavery, Kerry S.
    Irwin, Nigel
    O'Harte, Finbarr P. M.
    Harriott, Patrick
    Greer, Brett
    Bailey, Clifford J.
    Flatt, Peter R.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 318 (02): : 914 - 921
  • [32] The Importance of Endogenously Secreted GLP-1 and GIP for Postprandial Glucose Tolerance and β-Cell Function After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy Surgery
    Hindso, Morten
    Hedbaeck, Nora
    Svane, Maria S.
    Moller, Andreas
    Martinussen, Christoffer
    Jorgensen, Nils B.
    Dirksen, Carsten
    Gasbjerg, Laerke S.
    Kristiansen, Viggo B.
    Hartmann, Bolette
    Rosenkilde, Mette M.
    Holst, Jens J.
    Madsbad, Sten
    Bojsen-Moller, Kirstine N.
    DIABETES, 2023, 72 (03) : 336 - 347
  • [33] Glucokinase Activator Dorzagliatin (HMS5552) Regulates GLP-1 Release in T2D Patients and Is Synergistic with Sitagliptin and Empagliflozin in Optimizing Beta-Cell Function
    Chen, Li
    Zhang, Jiayi
    Yang, Rong
    Feng, Lingge
    Medicine, Hua
    DIABETES, 2021, 70
  • [34] Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlated with downregulation of GIP and GLP-1 receptors and impaired beta cell function
    Shu, L.
    Matveyenko, A. V.
    Kerr-Conte, J.
    Cho, J. -H.
    McIntosh, C. H. S.
    Maedler, K.
    DIABETOLOGIA, 2009, 52 : S38 - S38
  • [35] One week's treatment with NN2211, a long-acting GLP-1 derivative, markedly ameliorates 24-h glycemia and β-cell function and reduces fasting endogenous glucose release in type 2 diabetic patients
    Degn, K
    Juhl, C
    Sturis, J
    Jackobsen, G
    Chandramouli, V
    Rungby, J
    DIABETES, 2003, 52 : A116 - A116
  • [36] Decreased TCF7L2 Protein Levels in T2DM Correlate with Downregulation of GIP- and GLP-1 Receptors and Impaired beta-Cell Function
    Maedler, Kathrin
    Matveyenko, Aleksey V.
    Kerr-Conte, Julie
    Cho, Jae-Hyoung
    McIntosh, Christopher H. S.
    Shu, Luan
    DIABETES, 2009, 58 : A305 - A305
  • [37] Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function
    Shu, Luan
    Matveyenko, Aleksey V.
    Kerr-Conte, Julie
    Cho, Jae-Hyoung
    McIntosh, Christopher H. S.
    Maedler, Kathrin
    HUMAN MOLECULAR GENETICS, 2009, 18 (13) : 2388 - 2399
  • [38] Brain chemokine stromal cell-derived factor-1/CXCL12 modulates cardiovascular function and sympathetic drive in sham-operated and heart failure rats
    Wei, Shunguang
    Zhang, Zhihua
    Yu, Yang
    Weiss, Robert
    Felder, Robert B.
    FASEB JOURNAL, 2010, 24
  • [39] TCF7L2 gene associates with loss of residual beta-cell function and postprandial GLP-1 in young patients with new onset type 1 diabetes. Results from the hvidoere study group
    Nielsen, Lotte B.
    Porksen, Sven
    Hoey, Hilary
    Kocova, Mirjana
    Schonle, Eugen
    De Beaufort, Carine
    Hougaard, Philip
    Pociot, Flemming
    Knip, Mikael
    Holst, Jens J.
    Hansen, Lars
    Mortensen, Henrik B.
    DIABETES, 2008, 57 : A465 - A465
  • [40] One week's treatment with NN2211, a long-acting GLP-1 derivative, significantly improves first phase insulin response and other markers of β-cell function, reduces endogenous glucose release, and ameliorates 24-h glycemia in Type 2 diabetic patients.
    Degn, KB
    Juhl, CB
    Sturis, J
    Jakobsen, G
    Chandramouli, V
    Rungby, J
    Landau, BR
    Schmitz, OE
    DIABETOLOGIA, 2003, 46 : A285 - A285